Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (51-60 of 476) with videos related to

Pageof 48
Sort By:
Acta Dermato-Venereologica|September 2, 2004
Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitorMarkella-Pagona Zorzou, Alexandros Stratigos, Eleni Efstathiou, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Future Oncology (London, England)|January 19, 2021
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology databaseGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Cancer Genomics & Proteomics|May 18, 2012
In silico functional profiling of individual prostate cancer tumors: many genes, few functionsIvan P Gorlov, Jinyoung Byun, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
International Journal of Cancer|June 25, 2009
Housekeeping genes in prostate tumorigenesisJinyoung Byun, Christopher J Logothetis, Ivan P Gorlov
Nature Reviews. Drug Discovery|February 2, 2012
Medicinal chemistry: Shades of chemical beautyPeter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2012
Antiparasitic drugs: Two-pronged tactics for malaria controlPeter Kirkpatrick
Cancer Discovery|May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremesAna Aparicio, Christopher J Logothetis, Sankar N Maity
Seminars in Oncology|June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancerPaul Mathew, Isaiah J Fidler, Christopher J Logothetis
Pageof 48

Showing results (51-60 of 476) with videos related to

Sort By:
Pageof 48
Acta Dermato-Venereologica|September 2, 2004
Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitorMarkella-Pagona Zorzou, Alexandros Stratigos, Eleni Efstathiou, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Future Oncology (London, England)|January 19, 2021
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology databaseGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Cancer Genomics & Proteomics|May 18, 2012
In silico functional profiling of individual prostate cancer tumors: many genes, few functionsIvan P Gorlov, Jinyoung Byun, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
International Journal of Cancer|June 25, 2009
Housekeeping genes in prostate tumorigenesisJinyoung Byun, Christopher J Logothetis, Ivan P Gorlov
Nature Reviews. Drug Discovery|February 2, 2012
Medicinal chemistry: Shades of chemical beautyPeter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2012
Antiparasitic drugs: Two-pronged tactics for malaria controlPeter Kirkpatrick
Cancer Discovery|May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremesAna Aparicio, Christopher J Logothetis, Sankar N Maity
Seminars in Oncology|June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancerPaul Mathew, Isaiah J Fidler, Christopher J Logothetis
Pageof 48